Preventing blood clots after colorectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial tests a blood-thinning drug to prevent dangerous blood clots (venous thromboembolism) in people with colorectal cancer who are having surgery. It aims to see if the drug can help reduce clot risk safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have colorectal cancer that can be removed with surgery
- Your cancer has not spread to nearby organs or beyond (stage cT1-2 N0, cT3 N0, or any cT N1-2)
- Your surgery is expected to last longer than 45 minutes
- Your doctor expects you to live at least 6 months after surgery
- You are not taking blood thinners or have certain bleeding risks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at when to start blood thinners after surgery for colorectal cancer. The goal is to find the safest time to prevent blood clots without increasing bleeding risk.
This trial compares different blood clot prevention strategies for people over 18 with colorectal cancer who are having surgery lasting at least 45 minutes. It aims to find the best way to reduce the risk of dangerous blood clots after surgery.
This trial tests whether a longer course of blood-thinning injections after major liver surgery reduces the risk of blood clots. It may help people recovering from liver cancer surgery.
This trial tests a program to help people who had cancer surgery get medicine to prevent dangerous blood clots. If you had belly or pelvic cancer surgery and are not on blood thinners, you may be able to join.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
This Phase 3 study tests whether the medicine rivaroxaban can prevent dangerous blood clots in people with cancer who have a central venous catheter placed recently. It may help reduce clot risk while your catheter is in place, but you must meet safety and bleeding-risk criteria.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.